Sandy Spring Bank’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Sandy Spring Bank’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-750	Closed	-$560	–	1327
2024 Q4	$560	Hold	750	–	–	﹤0.01%	1130
2024 Q3	$915	Hold	750	–	–	﹤0.01%	1093
2024 Q2	$1.55K	Hold	750	–	–	﹤0.01%	1118
2024 Q1	$2.74K	Hold	750	–	–	﹤0.01%	1018
2023 Q4	$2.26K	Buy	750 +500	+200%	+$1.01K	﹤0.01%	1008
2023 Q3	$538	Buy	+250	New	+$999	﹤0.01%	1118

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Sandy Spring Bank's OMGA Position: Q1 2025 in Review

Sandy Spring Bank sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 750 shares — an estimated $560 sold.

Sandy Spring Bank first reported a position in OMGA in Q3 2023 and held it in 6 quarters. The position peaked at $2.74K in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Sandy Spring Bank reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Sandy Spring Bank sold 750 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $560.
Sandy Spring Bank first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2023 and held it in 6 quarters.
Sandy Spring Bank's Omega Therapeutics, Inc. Common Stock position peaked at $2.74K in Q1 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.